|
HTRF biomarkers
|
BAO_0003082 |
|
|
dna-seq method
|
BAO_0040026 |
|
|
variant construct assay
|
BAO_0000807 |
|
|
ViaLight Plus kit
|
BAO_0003083 |
|
|
chemiluminescent labeling method
|
BAO_0040025 |
|
|
QuantiChrom Assay Kit
|
BAO_0003084 |
|
|
thermal shift assessment method
|
BAO_0040024 |
|
|
maximal activation
|
BAO_0000805 |
|
|
LanthaScreen Co-Factor Interaction Assay
|
BAO_0003085 |
|
|
in vivo PK/PD/Tox method
|
BAO_0040023 |
|
|
in vivo assay method
|
BAO_0040021 |
|
|
LanthaScreen Competetive Binding Assay
|
BAO_0003086 |
|
|
maximal inhibition
|
BAO_0000804 |
|
|
in vivo efficacy method
|
BAO_0040022 |
|
|
sub-cellular morphology assessment method
|
BAO_0040020 |
|
|
systemic primary carnitine deficiency disease
|
DOID_14365 |
|
|
tick-borne relapsing fever
|
DOID_13036 |
|
|
EC 2.4.2.12 (nicotinamide phosphoribosyltransferase) inhibitor
|
CHEBI_231708 |
|
|
turns per second
|
UO_0000092 |
|
|
PolarScreen Competitor Assay Kit
|
BAO_0003076 |
|
